Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,056
Total Claims
$874K
Drug Cost
120
Beneficiaries
$7,286
Cost/Patient
Risk Score Breakdown 11/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+416%
Cost per patient vs peers
$7,286 vs $1,411 avg
+841%
Brand preference vs peers
100.0% vs 10.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 676 claims · $754K
Generic: 0 claims · $0
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 25 | $328K |
| Omalizumab | 26 | $109K |
| Fluticasone/Umeclidin/Vilanter | 88 | $80K |
| Umeclidinium Brm/Vilanterol Tr | 107 | $60K |
| Pirfenidone | 11 | $53K |
| Fluticasone/Vilanterol | 59 | $29K |
| Tiotropium Bromide | 36 | $20K |
| Budesonide/Formoterol Fumarate | 35 | $19K |
| Tiotropium Bromide | 26 | $16K |
| Umeclidinium Bromide | 32 | $15K |
| Tiotropium Br/Olodaterol Hcl | 14 | $15K |
| Varenicline Tartrate | 22 | $7,293 |
| Albuterol Sulfate | 163 | $5,598 |
| Roflumilast | 21 | $3,844 |
| Mometasone/Formoterol | 11 | $3,730 |
Prescribing Profile
19
Unique Drugs
11.0
Anomaly Score
Patient Profile
72
Avg Age
63%
Female
2.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About